
Your Feed
What is the PROMISE study?
All About Kyprolis (Carfilzomib) - Updated 2025
Should there be screening for precursor conditions as part of routine care?
How is smoldering multiple myeloma monitored? What testing should be done and how often?
What is plasma cell leukemia (PCL)? What is the difference between Primary PCL vs. secondary PCL?
Promising Results for Menin Inhibitors in Combination with 7+3 in AML | Amer Zeidan, MD | #EHA2025
Promising Results for Menin Inhibitors in Combination with 7+3 in AML | Amer Zeidan, MD | #EHA2025
Promising Results for Menin Inhibitors in Combination with 7+3 in AML | Amer Zeidan, MD | #EHA2025
Why consider an allo transplant in the age of novel therapies?
Why are newly diagnosed multiple myeloma (NDMM) patients at risk of infection? What precautions should NDMM patients take to prevent infections?
Imetelstat and Luspatercept in MDS Anemia | Valeria Santini, MD | #EHA2025
